Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
The 'Biden Biotech Boom' Will Send This Bargain Dividend Soaring
09:26am, Thursday, 15'th Sep 2022 Investing.com
Why Johnson & Johnson Was Such a Healthy Stock Today
09:55pm, Wednesday, 14'th Sep 2022 The Motley Fool
Investors cheered the pharmaceutical giant's latest move.
US Stocks Could Head For Recovery Today After Inflation-Report-Induced Bloodbath, Futures Trading Suggests — Nikola, JNJ, SoFi In Focus
10:59am, Wednesday, 14'th Sep 2022 Benzinga
U.S. stocks could pick up the shreds after the ravages inflicted by an inflation reading that came in more than expected. The major U.S. index futures are pointing to a higher open on Wednesday. On Tu
The Meta meltdown: This chart shows Facebook's fall from grace among the most valuable U.S. companies
11:27pm, Tuesday, 13'th Sep 2022 MarketWatch
Dogged by competitive and macroeconomic threats, Meta Platforms Inc. is sinking down the ranks of the largest U.S. companies.
These 3 Low-Beta Stocks Are Great Shields Against Volatility
08:10pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Investors could heavily benefit from an increased level of defense in their portfolios amid the challenging macroeconomic backdrop we've found ourselves in.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
10:20am, Tuesday, 13'th Sep 2022 Zacks Investment Research
Sector ETF report for IHE
Is Vanguard High Dividend Yield ETF (VYM) a Strong ETF Right Now?
10:20am, Tuesday, 13'th Sep 2022 Zacks Investment Research
Smart Beta ETF report for VYM
Should Vanguard S&P 500 Value ETF (VOOV) Be on Your Investing Radar?
10:20am, Tuesday, 13'th Sep 2022 Zacks Investment Research
Style Box ETF report for VOOV
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
09:45pm, Monday, 12'th Sep 2022 Zacks Investment Research
In the latest trading session, Johnson & Johnson (JNJ) closed at $165.64, marking a -0.04% move from the previous day.
Where Johnson & Johnson Stands With Analysts
09:05pm, Monday, 12'th Sep 2022 Benzinga
Over the past 3 months, 8 analysts have published their opinion on Johnson & Johnson (NYSE:JNJ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?
10:20am, Monday, 12'th Sep 2022 Zacks Investment Research
Sector ETF report for PJP
Should iShares S&P 500 Value ETF (IVE) Be on Your Investing Radar?
10:20am, Monday, 12'th Sep 2022 Zacks Investment Research
Style Box ETF report for IVE
3 Dividend Aristocrats Set to Win Big From Unstoppable Trends
09:57am, Sunday, 11'th Sep 2022 The Motley Fool
These great dividend stocks have clear tailwinds that should drive long-term growth.
Become Financially Independent, Stress-Free In 15 Years
01:00pm, Saturday, 10'th Sep 2022 Seeking Alpha
Being financially independent is a prerequisite for retirees but can be a great stress reducer for younger folks who are several years away from retirement. Read more here.
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
01:00pm, Friday, 09'th Sep 2022 Zacks Investment Research
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
